Stimulus-Responsive Nanomedicines for Disease Diagnosis and Treatment

Stimulus-responsive drug delivery systems generally aim to release the active pharmaceutical ingredient (API) in response to specific conditions and have recently been explored for disease treatments. These approaches can also be extended to molecular imaging to report on disease diagnosis and manag...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Gengqi, Lovell, Jonathan F., Zhang, Lei, Zhang, Yumiao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7504550/
https://www.ncbi.nlm.nih.gov/pubmed/32887466
http://dx.doi.org/10.3390/ijms21176380

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7504550/
https://www.ncbi.nlm.nih.gov/pubmed/32887466
http://dx.doi.org/10.3390/ijms21176380

Ejemplares similares